FDA recall, , Low risk
American National Red Cross Apheresis Platelets
Apheresis Platelets lacked documentation of time exposed to the Compound Absorption Device during pathogen reduction.
Recall ended Sep 29, 2026. Still check yours.
Summary by Recall Canary from the FDA notice
What happened
The American National Red Cross began a recall on September 3, 2024, of Apheresis Platelets, PAS, Leukocytes Reduced, Pathogen Reduced, because the product lacked documentation of time exposed to the Compound Absorption Device (CAD) during pathogen reduction. The FDA added the recall to its Enforcement Report on September 29, 2026, and classified it on the same date, with the recall listed in the FDA's weekly enforcement report on October 7, 2026. The product was distributed in New York.
What to do
We don't have product-specific instructions for this recall. FDA's general advice for medicine recalls:
- Check the FDA or company notice for instructions specific to this product.
- Ask your pharmacist or doctor whether your lot is affected and what to do.
Is yours affected?
Compare these details with yours, then check the recall notice to see which units are recalled.
Apheresis Platelets, PAS, Leukocytes Reduced, Pathogen Reduced
Recall details
- Company began the recall
- Sold in
- Company
- American National Red Cross (the)
- Hazard
- Contamination
- Risk
Low risk
Taking it is unlikely to cause health problems.
FDA Class III recall · How risk is rated
- Event ID
- 99819
- Recall number
- B-0231-2026
All recalls from American National Red Cross (the)
Timeline
FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.
Company began the recall
Added to FDA's Enforcement Report · Classified by FDA · Recall ended
In FDA's weekly enforcement report
Listed on Recall Canary
